Schonfeld Strategic Advisors LLC Acumen Pharmaceuticals, Inc. Transaction History

Schonfeld Strategic Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.14 - $4.01 $823,611 - $1.54 Million	-384,865 Reduced 83.94%	73,619 $178,000
Q1 2024 May 15, 2024	SELL	$2.97 - $4.64 $306,082 - $478,189	-103,058 Reduced 18.35%	458,484 $1.86 Million
Q4 2023 Feb 14, 2024	SELL	$1.86 - $4.48 $155,440 - $374,393	-83,570 Reduced 12.95%	561,542 $2.16 Million
Q3 2023 Nov 14, 2023	BUY	$4.15 - $9.72 $2.68 Million - $6.27 Million	645,112 New	645,112 $2.68 Million
Q3 2022 Nov 14, 2022	BUY	$4.44 - $10.48 $161,616 - $381,472	36,400 Added 31.37%	152,429 $1.53 Million
Q2 2022 Aug 15, 2022	BUY	$3.08 - $4.88 $90,816 - $143,891	29,486 Added 34.07%	116,029 $545,000
Q4 2021 Feb 14, 2022	BUY	$6.54 - $15.31 $565,991 - $1.32 Million	86,543 New	86,543 $585,000

41.8M

57.7K

749K

Ticker ABOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,503,100
Market Cap $72.5M
Description
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.